Craig brooks
Faculty Member
Last active: 3/14/2019

  1. Cyclin G1 and TASCC regulate kidney epithelial cell G-M arrest and fibrotic maladaptive repair. Canaud G, Brooks CR, Kishi S, Taguchi K, Nishimura K, Magassa S, Scott A, Hsiao LL, Ichimura T, Terzi F, Yang L, Bonventre JV (2019) Sci Transl Med 11(476)
    › Primary publication · 30674655 (PubMed) · PMC6527117 (PubMed Central)
  2. RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice. Taguchi K, Yamagishi SI, Yokoro M, Ito S, Kodama G, Kaida Y, Nakayama Y, Ando R, Yamada-Obara N, Asanuma K, Matsui T, Higashimoto Y, Brooks CR, Ueda S, Okuda S, Fukami K (2018) Sci Rep 8(1): 2686
    › Primary publication · 29422652 (PubMed) · PMC5805738 (PubMed Central)
  3. Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development. Kim YK, Refaeli I, Brooks CR, Jing P, Gulieva RE, Hughes MR, Cruz NM, Liu Y, Churchill AJ, Wang Y, Fu H, Pippin JW, Lin LY, Shankland SJ, Vogl AW, McNagny KM, Freedman BS (2017) Stem Cells 35(12): 2366-2378
    › Primary publication · 28905451 (PubMed) · PMC5742857 (PubMed Central)
  4. TIM-1 signaling is required for maintenance and induction of regulatory B cells. Yeung MY, Ding Q, Brooks CR, Xiao S, Workman CJ, Vignali DA, Ueno T, Padera RF, Kuchroo VK, Najafian N, Rothstein DM (2015) Am J Transplant 15(4): 942-53
    › Primary publication · 25645598 (PubMed) · PMC4530122 (PubMed Central)
  5. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. Xiao S, Brooks CR, Sobel RA, Kuchroo VK (2015) J Immunol 194(4): 1602-8
    › Primary publication · 25582854 (PubMed) · PMC4346345 (PubMed Central)
  6. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad AF, Li MK, Hughes MR, Werff RV, Peters DT, Lu J, Baccei A, Siedlecki AM, Valerius MT, Musunuru K, McNagny KM, Steinman TI, Zhou J, Lerou PH, Bonventre JV (2015) Nat Commun : 8715
    › Primary publication · 26493500 (PubMed) · PMC4620584 (PubMed Central)
  7. Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury. Kishi S, Campanholle G, Gohil VM, Perocchi F, Brooks CR, Morizane R, Sabbisetti V, Ichimura T, Mootha VK, Bonventre JV (2015) EBioMedicine 2(9): 1090-101
    › Primary publication · 26501107 (PubMed) · PMC4588407 (PubMed Central)
  8. KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation. Brooks CR, Yeung MY, Brooks YS, Chen H, Ichimura T, Henderson JM, Bonventre JV (2015) EMBO J 34(19): 2441-64
    › Primary publication · 26282792 (PubMed) · PMC4601664 (PubMed Central)
  9. KIM-1/TIM-1 in proximal tubular cell immune response. Brooks CR, Bonventre JV (2015) Oncotarget 6(42): 44059-60
    › Primary publication · 26683362 (PubMed) · PMC4792540 (PubMed Central)
  10. KIM-1-mediated phagocytosis reduces acute injury to the kidney. Yang L, Brooks CR, Xiao S, Sabbisetti V, Yeung MY, Hsiao LL, Ichimura T, Kuchroo V, Bonventre JV (2015) J Clin Invest 125(4): 1620-36
    › Primary publication · 25751064 (PubMed) · PMC4396492 (PubMed Central)